Title : Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases.

Pub. Date : 1995

PMID : 7549905






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Olomoucine (2-(2-hydroxyethylamino)-6-benzylamino-9-methylpurine) has been recently described as a competitive inhibitor (ATP-binding site) of the cell cycle regulating p34cdc2/cyclin B, p33cdk2/cyclin A and p33cdk2/cyclin E kinases, the brain p33cdk5/p35 kinase and the ERK1/MAP-kinase. Adenosine Triphosphate mitogen-activated protein kinase 3 Mus musculus